Information Provided By: 
Fly News Breaks for May 1, 2018
AXGN
May 1, 2018 | 07:05 EDT
Cantor Fitzgerald analyst Craig Bijou raised his price target for AxoGen to $45 saying the "solid" Q1 sets the stage for a "strong" 2018. Although the beat was modest, AxoGen "weathered disruption from changes to its sales force in January and quickly rebounded with a record March," Bijou tells investors in a post-earnings research note. The analyst, however, thinks expectations may have gotten too high and that the stock may be under pressure. He views any pullback as a buying opportunity and reiterates an Overweight rating on AxoGen.
News For AXGN From the Last 2 Days
There are no results for your query AXGN
